L3VLUP
ProSign in

QURE in the 13F filings

Uniqure NV · CUSIP N90064101

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
15 Aug 2024
latest of these filings; the earliest 14 Aug 2024
Managers listing it
3
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 3 listed it in both
Shares listed
1,008,118
combined, among listed positions
Reported value
$4.5m
combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +301,253.

Managers listing QURE in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

3 of 3 holders

ActionFiling
Hudson Bay Capital Management LP809,117$3.6munder 0.1%Added+284,11714 Aug 2024 (the filing on sec.gov)
PDT Partners LLC139,001$623k0.06%Added+17,13615 Aug 2024 (the filing on sec.gov)
Moore Capital Management LP60,000$269kunder 0.1%Held014 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

03581020142015201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
QURE by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20141$779kn.a.n.a.
Q2 20142$5.5mn.a.n.a.
Q3 20142$3.7mn.a.n.a.
Q4 20141$5.2mn.a.n.a.
Q1 20151$2.2mn.a.n.a.
Q2 20151$15mn.a.n.a.
Q3 20151$11mn.a.n.a.
Q4 20151$7.7mn.a.n.a.
Q2 20161$4.1mn.a.n.a.
Q3 20161$4.5mn.a.n.a.
Q4 20171$2.7mn.a.n.a.
Q1 20181$3.2mn.a.n.a.
Q2 20181$669kn.a.n.a.
Q1 20191$1.0mn.a.n.a.
Q2 20195$49mn.a.n.a.
Q3 20197$54mn.a.n.a.
Q4 201910$581mn.a.n.a.
Q1 20205$258mn.a.n.a.
Q2 20208$143mn.a.n.a.
Q3 20206$144mn.a.n.a.
Q4 20207$90mn.a.n.a.
Q1 20215$117mn.a.n.a.
Q2 20215$103mn.a.n.a.
Q3 20215$69mn.a.n.a.
Q4 20213$48mn.a.n.a.
Q1 20223$66mn.a.n.a.
Q2 20225$94mn.a.n.a.
Q3 20223$111mn.a.n.a.
Q4 20224$50mn.a.n.a.
Q1 20237$47mn.a.n.a.
Q2 20234$9.4mn.a.n.a.
Q3 20234$8.2mn.a.n.a.
Q4 20233$4.0m11
Q1 20243$3.7m20
Q2 20243$4.5m20
Q3 20241$493k10
Q4 20245$57m41
Q1 20252$1.7m10
Q2 20252$2.6m10
Q3 20256$130m33
Q4 20256$80m1512
Q1 20264$21m1211
Q2 20263$111m1215

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

QURE and LLY →QURE and JNJ →QURE and VRTX →Choose a stock to compare with QURE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own QURE, latest filings →Back to the 13F Explorer →